Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011:7:251-7.
doi: 10.2147/NDT.S19177. Epub 2011 May 6.

Nondrug-related aspect of treating Ekbom disease, formerly known as restless legs syndrome

Ulrike H Mitchell  1
Affiliations

Nondrug-related aspect of treating Ekbom disease, formerly known as restless legs syndrome

Ulrike H Mitchell. Neuropsychiatr Dis Treat. 2011.

Abstract

Ekbom disease (EKD), formerly known as restless legs syndrome (RLS) has affected and bothered many people over the centuries. It is one of the most prevalent neurological disorders in Europe and North-America, affecting about 10% of the population. The main characteristics are the strong urge to move, accompanied or caused by uncomfortable, sometimes even distressing, paresthesia of the legs, described as a "creeping, tugging, pulling" feeling. The symptoms often become worse as the day progresses, leading to sleep disturbances or sleep deprivation, which leads to decreased alertness and daytime functions. Numerous studies have been conducted assessing the efficacy of dopaminergic drugs, opioids, and other pharmacologic agents in alleviating EKD symptoms. However, there is also a growing body of evidence demonstrating the effectiveness of nonpharmacologic treatments including life style changes, physical activity programs, pneumatic compression, massage, near-infrared light therapy, and complementary therapies. The working mechanisms behind these alternatives are diverse. Some increase blood flow to the legs, therefore reducing tissue hypoxia; some introduce an afferent counter stimulus to the cortex and with that "close the gate" for aberrant nerve stimulations; some increase dopamine and nitric oxide and therefore augment bio-available neurotransmitters; and some generate endorphins producing an analgesic effect. The advantages of these treatments compared with pharmacologic agents include less or no side effects, no danger of augmentation, and less cost.

Keywords: NIR; RLS; intermittent compression; massage; modalities.

PubMed Disclaimer

Figures

Figure 1
Figure 1
EKD treatment options and their potential working mechanisms. Abbreviation: EKD, Ekbom disease.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Ekbom K. Restless legs syndrome. Neurology. 1960;10:868–873. - PubMed
    1. Coccagna G, Vetrugno R, Lombardi C, Provini F. Restless legs syndrome: an historical note. Sleep Med. 2004;5:279–283. - PubMed
    1. Benes H. Was gibt es Neues zum Restless-legs-Syndrom? Psychoneuro. 2004;30(8):438–443.
    1. Berger K, Luedemann J, Trenkwalder C, John U, Kessler C. Sex and the risk of restless legs syndrome in the general population. Arch Intern Med. 2004;164:196–202. - PubMed
    1. Kushida C, Allen R, Atkinson M. Modeling the causal relationship between symptoms associated with restless legs syndrome and the patient-reported impact of RLS. Sleep Med. 2004;5:485–488. - PubMed